GUGGENHEIM CAPITAL LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 85 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$806,470
-18.5%
68,988
-6.3%
0.01%
-12.5%
Q2 2023$989,372
-5.4%
73,614
+16.7%
0.01%
-11.1%
Q1 2023$1,045,585
+154.7%
63,063
+185.7%
0.01%
+125.0%
Q4 2022$410,558
+161.5%
22,073
+80.9%
0.00%
+300.0%
Q3 2022$157,000
+166.1%
12,202
-51.3%
0.00%
Q1 2018$59,000
-35.2%
25,067
+6.6%
0.00%
Q4 2017$91,000
+33.8%
23,516
-13.7%
0.00%
Q3 2017$68,000
-8.1%
27,244
+0.1%
0.00%
Q2 2017$74,000
+51.0%
27,226
+9.0%
0.00%
Q1 2017$49,000
+122.7%
24,984
+17.1%
0.00%
Q4 2016$22,000
-4.3%
21,3350.0%0.00%
Q3 2016$23,000
+53.3%
21,335
-1.2%
0.00%
Q2 2016$15,000
-44.4%
21,595
-7.5%
0.00%
Q1 2016$27,000
-62.5%
23,355
-19.9%
0.00%
Q4 2015$72,000
+22.0%
29,144
+49.6%
0.00%
Q3 2015$59,000
-28.0%
19,479
-2.1%
0.00%
Q2 2015$82,000
+67.3%
19,896
+75.2%
0.00%
Q1 2015$49,000
+8.9%
11,355
-36.0%
0.00%
Q2 2014$45,000
+2.3%
17,744
-9.1%
0.00%
Q1 2014$44,000
+51.7%
19,518
+29.4%
0.00%
Q4 2013$29,000
-32.6%
15,082
+6.3%
0.00%
Q3 2013$43,000
+290.9%
14,187
+15.3%
0.00%
Q2 2013$11,00012,3040.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders